2466例超声软指标胎儿的产前染色体微阵列分析:前瞻性队列研究
该前瞻性队列纳入2466例孕中期超声软指标胎儿,采用单核苷酸多态性微阵列(SNP array)检测并长期随访,总体染色体异常率为4.3%。多发软指标与颈褶增厚组非整倍体发生率更高,多发软指标与股骨短组致病性拷贝数变异发生率更高。提出基于特定软指标类型的产前遗传检测算法。
要点
- 软指标胎儿总体染色体异常率4.3%,其中致病性拷贝数变异占48.6%。
- 多发软指标和颈褶增厚者非整倍体风险显著升高。
- 多发软指标和股骨短者致病性拷贝数变异风险显著升高。
核心结论
- 不同类型孤立软指标的染色体异常风险和临床预后差异大。
- 致病性拷贝数变异更常见于特定软指标,尤其是多发软指标时。
研究设计与样本
- 前瞻性队列研究,纳入2466例孕中期超声软指标胎儿,行SNP array检测并长期随访,历时5年。
- 软指标分为12组,比较各组人口学特征和染色体微阵列分析结果。
主要发现
- 总体染色体异常率为4.3%(107/2466),其中非整倍体占40.2%,致病性拷贝数变异占48.6%,可能致病性拷贝数变异占11.2%。
- 多发软指标组非整倍体发生率5.5% vs 1.5%(P=.001),颈褶增厚组8.3% vs 1.7%(P=.024)。
- 多发软指标组致病性拷贝数变异发生率5.5% vs 2.4%(P=.046),股骨短组6.6% vs 2.2%(P<.0001)。
- 孤立性心内强回声、小脑延髓池增宽、脉络丛囊肿、肠管强回声或单脐动脉的致病性拷贝数变异发生率均低于1.5%。
- 无染色体异常胎儿的正常婴儿率为91.7%,轻度脑室增宽组86.2% vs 93.0%(P<.0001),股骨短组71.4% vs 93.6%(P<.0001)。
临床怎么用
- 针对不同孤立软指标类型,可参考本研究提出的基于软指标类型的产前遗传检测算法。
- 多发软指标、颈褶增厚、股骨短时,应更积极考虑染色体微阵列分析。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Soft markers are nonspecific findings detected by ultrasonography during the second trimester that are often transient and nonpathologic but may imply an increased risk of underlying fetal aneuploidy. However, large-scale prospectively stratified studies focusing on the prevalence of chromosomal aberrations, including copy number variants, in fetuses with different types of isolated soft markers have rarely been published in the literature. OBJECTIVE: This study aimed to investigate clinical outcomes in fetuses with isolated soft markers by single nucleotide polymorphism array with long-term follow-up and to propose a diagnostic algorithm based on specific types of soft markers. STUDY DESIGN: The prevalence of fetal isolated soft markers was 13.2% (7869 of 59,503). A total of 2466 fetuses with ultrasonographic soft markers during the second trimester, which were subjected to single nucleotide polymorphism array with long-term follow-up, were selected in this prospective study over a 5-year period. Soft markers were categorized into 12 groups. The demographic profile and chromosomal microarray analysis detection results were analyzed and compared among different groups. RESULTS: The overall prevalence of chromosomal aberrations in fetuses with soft markers was 4.3% (107 of 2466), which comprised 40.2% with numeric chromosomal abnormalities, 48.6% with pathogenic copy number variants, and 11.2% with likely pathogenic copy number variants. The incidence of numeric chromosomal abnormalities was significantly higher in multiple soft markers (5.5% vs 1.5%; P=.001) and the thickened nuchal fold group (8.3% vs 1.7%; P=.024). Meanwhile, the incidence of pathogenic copy number variants was significantly higher in multiple soft markers (5.5% vs 2.4%; P=.046) and the short femur length group (6.6% vs 2.2%; P<.0001). The incidences of pathogenic copy number variants in fetuses with isolated echogenic intracardiac focus, enlarged cisterna magna, choroid plexus cysts, echogenic bowel, or single umbilical artery were lower than 1.5%. The normal infant rate in fetuses without chromosomal aberrations was 91.7%; however, it was significantly lower in the mild ventriculomegaly (86.2% vs 93.0%; P<.0001) and short femur length groups (71.4% vs 93.6%; P<.0001). CONCLUSION: The potential chromosomal aberrations and clinical prognoses varied widely among different types of isolated soft markers. Pathogenic copy number variants are more often present in specific soft markers, especially when multiple soft markers are found. Thus, a specific soft marker type-based prenatal genetic testing algorithm was proposed.
引用
- Hu T, Tian T, Zhang Z, et al. Prenatal chromosomal microarray analysis in 2466 fetuses with ultrasonographic soft markers: a prospective cohort study. Am J Obstet Gynecol. 2020. PMID: 33122027. doi:10.1016/j.ajog.2020.10.039
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。